DUBLIN, Oct. 19, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9b5zsl/europe) has announced the addition of the "Europe Electrophysiology and Ablation Devices Market - 2016 (Forecasted to 2022)" report to their offering.
The electrophysiology (EP) and ablation device market includes ablation catheters, diagnostic EP catheters, intracardiac ultrasound (ICE) catheters, cryoablation catheters and various EP lab systems. Over the forecast period, the electrophysiology and ablation device market will be driven by the aging population, rise in cardiac ablation procedures and adoption of advanced EP devices. For the relatively newer devices used in electrophysiology and ablation markets, continued education is critical to increase cardiologists' confidence in these types of cardiac treatments.
The EP market is expected to experience growth across all product segments over the forecast period. The more recent products are expected to experience strong growth on a percentage basis but not on an absolute unit or market growth basis simply because newer devices take a while for physicians to adopt. Also, considering the severity of the procedures, it will take years of practice before a device can fully take off. Therefore, most of the devices sold for newer market segments will go towards training and clinical studies.
Throughout the forecast period, there is expected to be a significant growth in demand for catheter-based ablation procedures due to an increase in public knowledge, technological improvements and an increase in the number of EP labs in rural areas.
Biosense Webster was the leading competitor in the EP lab system, ablation catheter and diagnostic EP catheter markets. The company has been able to maintain its dominant position in the market by offering a wide range of EP and ablation devices while utilizing their expansive distribution network to improve sales. The company retains its title as majority market leader in ablation with nearly 50% of the entire market.
Other major competitors in the market include Angiodynamics, Biotronik, Boston Scientific, GE Healthcare, MicroPort, Siemens, Stereotaxis, St. Jude Medical and Topera. Certain companies, such as Boston Scientific and St. Jude Medical, also offer a wide range of EP and ablation products and sell them through large distribution networks.
This Report Includes Segments On:
This Report Includes:
For more information visit http://www.researchandmarkets.com/research/9b5zsl/europe
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets